Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed Dye Laser and Kligman's Trio for Melasma
NCT00863278Phase 4Terminated
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluocinolone acetonide + hydroquinone + tretinoin in melasma, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoints: Melasma Area and Severity Index at 18 weeks and Standardized photos in direct, crossed polarized and UV light at 18 weeks. Started Mar 2009; status: terminated.
02
Drugs
fluocinolone acetonide + hydroquinone + tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT00863278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863278.